Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last CNY9.40 CNY
Change Today +0.04 / 0.43%
Volume 6.4M
300142 On Other Exchanges
As of 2:00 AM 02/5/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Building 9A, Dingyi Tiancheng Residential Quarter

19th Floor

Keyuan Road No. 99

High & New Tech Development Zone

Kunming, 650106


Phone: 86 871 6831 2659

Fax: 86 871 6831 2567

Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, engages in the research and development, production, and sale of bio-medicine products in the People’s Republic of China. It offers bio-medicines, such as vaccines, blood products, and others. The company provides Group A and C meningococcal polysaccharide vaccine for children over the age of 2 years and adults to prevent disease caused by the bacteria named neisseria meningitidis groups A and group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent meningococcal disease caused by epidemic Neisseria meningitidis serogroups A, C, Y, and W-135. It also offers Group A, C meningococcal polysaccharide conjugate vaccine for infants from the age of 3 months to 5 years preventing diseases, such as cerebrospinal meningitis and septicemia; haemophilus influenzae type b conjugate vaccine for infants from the age of 2 months to 5 years to induce immunization against infectious diseases, including meningitis, pneumonia, septicemia, cellulitis, arthritis, epiglottitis, etc. In addition, the company offers prefilled syringe dosage form of haemophilus influenzae type b conjugate vaccine. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, the People’s Republic of China.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300142:CH CNY9.40 CNY +0.04

300142 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300142.
View Industry Companies

Industry Analysis


Industry Average

Valuation 300142 Industry Range
Price/Earnings 70.2x
Price/Sales 15.0x
Price/Book 4.4x
Price/Cash Flow 70.2x
TEV/Sales 11.0x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact WALVAX BIOTECHNOLOGY CO-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at